CORT
Corcept Therapeutics Incorporated
116.20$
+1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2,219.2% | -10.2% | -45.9% | +305.5% | -36.9% | -67.2% | +79.2% | +11.4% | +23.9% | +2.4% | +58.7% | +149.0% | -36.4% | -45.1% | +50.0% | +32.4% | +220.8% | +41.3% | +32.3% | +38.7% | -25.9% | +37.7% | +6.5% | +35.2% | -0.5% | |
| – | – | – | – | +225.6% | -22.8% | -66.8% | +80.2% | +10.9% | +24.7% | +2.4% | +59.1% | +139.0% | -38.7% | -48.2% | +62.0% | +34.1% | +114.0% | +71.1% | +27.8% | +70.6% | -49.2% | +87.4% | -8.1% | +2.8% | +2.9% | |
| – | – | – | -45.3% | -41.1% | -35.7% | +133.4% | +28.4% | +28.7% | +62.2% | +3.0% | +61.3% | +134.7% | -41.0% | -55.8% | +66.8% | +27.5% | +101.8% | +98.8% | -84.9% | +1,425.1% | -83.7% | -14.5% | +104.4% | -5.8% | -5.6% | |
| – | – | – | – | +223.1% | -22.2% | -67.5% | +83.7% | +5.4% | +30.4% | +3.0% | +61.3% | +134.7% | -41.0% | -55.8% | +66.8% | +27.5% | +101.8% | +98.8% | +33.5% | +72.8% | -53.1% | +93.1% | -14.7% | +4.1% | -2.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +156.4% | +133.5% | +86.6% | +58.5% | +186.0% | -37.6% | +13.3% | +31.5% | +10.8% | +61.4% | +21.3% | +2.2% | +2.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +28.5% | +10.1% | +39.4% | +38.5% | +259.6% | +93.9% | -66.6% | +290.1% | -76.4% | +22.3% | +26.7% | +60.6% | +3.7% | |
| – | – | – | -95.7% | – | – | -26.9% | -34.2% | -20.0% | -50.0% | -60.0% | +550.0% | +476.9% | +35.3% | +16.3% | -58.5% | +109.2% | +152.7% | +26.4% | +60.3% | +59.5% | -40.2% | +77.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +51.7% | +2,221.4% | -96.5% | +18.6% | +95.3% | -0.6% | -15.0% | -4.7% | -15.7% | +59.6% | +30.2% | +643.9% | +12.5% | -9.6% | -12.0% | -18.1% | +8.0% | +21.1% | +14.8% | +17.7% | -0.9% | +70.2% | +40.7% | +40.2% | +17.3% | |
| – | – | – | -33.2% | +79.9% | +93.0% | -0.2% | -14.8% | -4.4% | -15.5% | +59.6% | +30.2% | +66.3% | +52.4% | +6.4% | +54.0% | +31.1% | +8.0% | +21.1% | +8.5% | -72.8% | +350.5% | +52.5% | +44.2% | +34.7% | +18.0% | |
| – | – | – | – | – | – | +8.3% | +0.0% | -23.1% | -40.0% | – | – | – | +116.7% | +64.1% | +58.8% | -2.0% | – | – | – | +31.6% | -74.3% | +117.3% | -86.8% | +449.0% | +30.8% | |
| – | – | – | -60.0% | +70.9% | -0.2% | +66.8% | +21.7% | +17.0% | -2.6% | -35.7% | +342.0% | +5.3% | -37.4% | -20.8% | -29.7% | +72.8% | +274.6% | -3.6% | -8.8% | +40.0% | -34.5% | +73.4% | +45.3% | -11.6% | +163.0% | |
| – | – | – | +4.2% | – | – | -31.0% | -44.8% | -62.5% | – | – | – | – | +1.0% | -16.6% | -48.6% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | -198.1% | – | +348.6% | -42.1% | -76.1% | +131.7% | +14.7% | +30.7% | -3.8% | +63.8% | +77.5% | -66.0% | -116.1% | – | +123.7% | +361.5% | +44.5% | +34.5% | +41.0% | -28.2% | +33.5% | +1.0% | +34.1% | -4.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +136.5% | +52.0% | +35.8% | +35.1% | +18.3% | |
| – | – | +25.0% | +28.7% | +113.2% | +22.6% | +1.0% | +50.0% | +36.4% | +12.2% | +30.3% | +21.9% | +11.7% | +7.3% | +1.2% | +5.8% | +8.7% | +7.2% | +1.7% | -3.3% | +1.3% | +1.4% | -7.9% | -3.6% | +1.6% | +5.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.